Skip to main content
Figure 5 | Molecular Medicine

Figure 5

From: Safety and Efficacy of ARA 290 in Sarcoidosis Patients with Symptoms of Small Fiber Neuropathy: A Randomized, Double-Blind Pilot Study

Figure 5

ARA 290 administration was associated with a significant improvement in the autonomic component of the SFNSL. ARA 290 administration was associated with a significant improvement in the autonomic component of the SFNSL at wk 4 compared with baseline (*p < 0.05). Although a similar change was noted in the pain subcategory, the magnitude did not differ significantly from that of the placebo group.

Back to article page

Molecular Medicine

ISSN: 1528-3658